List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Pharmaceutical Contract Development and Manufacturing Market Size Analysis from 2023 to 2028
1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Pharmaceutical Contract Development and Manufacturing Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Pharmaceutical Contract Development and Manufacturing Industry Impact
Chapter 2 Global Pharmaceutical Contract Development and Manufacturing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pharmaceutical Contract Development and Manufacturing (Volume and Value) by Type
2.1.1 Global Pharmaceutical Contract Development and Manufacturing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Type (2017-2022)
2.2 Global Pharmaceutical Contract Development and Manufacturing (Volume and Value) by Application
2.2.1 Global Pharmaceutical Contract Development and Manufacturing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Application (2017-2022)
2.3 Global Pharmaceutical Contract Development and Manufacturing (Volume and Value) by Regions
2.3.1 Global Pharmaceutical Contract Development and Manufacturing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Pharmaceutical Contract Development and Manufacturing Consumption by Regions (2017-2022)
4.2 North America Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Pharmaceutical Contract Development and Manufacturing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Pharmaceutical Contract Development and Manufacturing Market Analysis
5.1 North America Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
5.1.1 North America Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
5.2 North America Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
5.3 North America Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
5.4 North America Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
5.4.1 United States Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
5.4.2 Canada Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
5.4.3 Mexico Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Pharmaceutical Contract Development and Manufacturing Market Analysis
6.1 East Asia Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
6.1.1 East Asia Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
6.2 East Asia Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
6.3 East Asia Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
6.4 East Asia Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
6.4.1 China Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
6.4.2 Japan Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
6.4.3 South Korea Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 7 Europe Pharmaceutical Contract Development and Manufacturing Market Analysis
7.1 Europe Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
7.1.1 Europe Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
7.2 Europe Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
7.3 Europe Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
7.4 Europe Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
7.4.1 Germany Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.2 UK Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.3 France Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.4 Italy Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.5 Russia Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.6 Spain Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
7.4.9 Poland Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Pharmaceutical Contract Development and Manufacturing Market Analysis
8.1 South Asia Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
8.1.1 South Asia Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
8.2 South Asia Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
8.3 South Asia Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
8.4 South Asia Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
8.4.1 India Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Analysis
9.1 Southeast Asia Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
9.1.1 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
9.2 Southeast Asia Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
9.3 Southeast Asia Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
9.4 Southeast Asia Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
9.4.1 Indonesia Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
9.4.2 Thailand Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
9.4.3 Singapore Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
9.4.5 Philippines Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Pharmaceutical Contract Development and Manufacturing Market Analysis
10.1 Middle East Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
10.1.1 Middle East Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
10.2 Middle East Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
10.3 Middle East Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
10.4 Middle East Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
10.4.1 Turkey Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.3 Iran Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.5 Israel Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.6 Iraq Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.7 Qatar Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
10.4.9 Oman Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 11 Africa Pharmaceutical Contract Development and Manufacturing Market Analysis
11.1 Africa Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
11.1.1 Africa Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
11.2 Africa Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
11.3 Africa Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
11.4 Africa Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
11.4.1 Nigeria Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
11.4.2 South Africa Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
11.4.3 Egypt Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
11.4.4 Algeria Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
11.4.5 Morocco Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Pharmaceutical Contract Development and Manufacturing Market Analysis
12.1 Oceania Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
12.2 Oceania Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
12.3 Oceania Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
12.4 Oceania Pharmaceutical Contract Development and Manufacturing Consumption by Top Countries
12.4.1 Australia Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 13 South America Pharmaceutical Contract Development and Manufacturing Market Analysis
13.1 South America Pharmaceutical Contract Development and Manufacturing Consumption and Value Analysis
13.1.1 South America Pharmaceutical Contract Development and Manufacturing Market Under COVID-19
13.2 South America Pharmaceutical Contract Development and Manufacturing Consumption Volume by Types
13.3 South America Pharmaceutical Contract Development and Manufacturing Consumption Structure by Application
13.4 South America Pharmaceutical Contract Development and Manufacturing Consumption Volume by Major Countries
13.4.1 Brazil Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.2 Argentina Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.3 Columbia Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.4 Chile Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.6 Peru Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Pharmaceutical Contract Development and Manufacturing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Pharmaceutical Contract Development and Manufacturing Business
14.1 AbbVie Inc.
14.1.1 AbbVie Inc. Company Profile
14.1.2 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product Specification
14.1.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Aenova Group
14.2.1 Aenova Group Company Profile
14.2.2 Aenova Group Pharmaceutical Contract Development and Manufacturing Product Specification
14.2.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Recipharm AB
14.3.1 Recipharm AB Company Profile
14.3.2 Recipharm AB Pharmaceutical Contract Development and Manufacturing Product Specification
14.3.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Catalent, Inc.
14.4.1 Catalent, Inc. Company Profile
14.4.2 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product Specification
14.4.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Thermo Fisher Scientific Inc.
14.5.1 Thermo Fisher Scientific Inc. Company Profile
14.5.2 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product Specification
14.5.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Lonza Group Ltd
14.6.1 Lonza Group Ltd Company Profile
14.6.2 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product Specification
14.6.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Almac Group
14.7.1 Almac Group Company Profile
14.7.2 Almac Group Pharmaceutical Contract Development and Manufacturing Product Specification
14.7.3 Almac Group Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 FAMAR Health Care Services
14.8.1 FAMAR Health Care Services Company Profile
14.8.2 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product Specification
14.8.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Vetter Pharma International GMBH
14.9.1 Vetter Pharma International GMBH Company Profile
14.9.2 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product Specification
14.9.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Consort Medical plc
14.10.1 Consort Medical plc Company Profile
14.10.2 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product Specification
14.10.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Siegfried Holding AG
14.11.1 Siegfried Holding AG Company Profile
14.11.2 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product Specification
14.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Boehringer Ingelheim International GmbH
14.12.1 Boehringer Ingelheim International GmbH Company Profile
14.12.2 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product Specification
14.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Evonik Industries AG
14.13.1 Evonik Industries AG Company Profile
14.13.2 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product Specification
14.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Pharmaceutical Contract Development and Manufacturing Market Forecast (2023-2028)
15.1 Global Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Pharmaceutical Contract Development and Manufacturing Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Pharmaceutical Contract Development and Manufacturing Value and Growth Rate Forecast (2023-2028)
15.2 Global Pharmaceutical Contract Development and Manufacturing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Pharmaceutical Contract Development and Manufacturing Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Pharmaceutical Contract Development and Manufacturing Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Pharmaceutical Contract Development and Manufacturing Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Pharmaceutical Contract Development and Manufacturing Consumption Forecast by Type (2023-2028)
15.3.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Forecast by Type (2023-2028)
15.3.3 Global Pharmaceutical Contract Development and Manufacturing Price Forecast by Type (2023-2028)
15.4 Global Pharmaceutical Contract Development and Manufacturing Consumption Volume Forecast by Application (2023-2028)
15.5 Pharmaceutical Contract Development and Manufacturing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
